Literature DB >> 27567406

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Jose Luis Zamorano, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J Lenihan, Gregory Y H Lip, Alexander R Lyon, Teresa Lopez Fernandez, Dania Mohty, Massimo F Piepoli, Juan Tamargo, Adam Torbicki, Thomas M Suter.   

Abstract

Entities:  

Keywords:  European Society of Cardiology; arrhythmias; cancer therapy; cardio-oncology; cardiotoxicity; chemotherapy; early detection; ischaemia; myocardial dysfunction; surveillance

Mesh:

Substances:

Year:  2016        PMID: 27567406     DOI: 10.1093/eurheartj/ehw211

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  562 in total

1.  Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Authors:  Dylan J Richards; Yang Li; Charles M Kerr; Jenny Yao; Gyda C Beeson; Robert C Coyle; Xun Chen; Jia Jia; Brooke Damon; Robert Wilson; E Starr Hazard; Gary Hardiman; Donald R Menick; Craig C Beeson; Hai Yao; Tong Ye; Ying Mei
Journal:  Nat Biomed Eng       Date:  2020-04-13       Impact factor: 25.671

2.  Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.

Authors:  Joe-Elie Salem; Tao Yang; Javid J Moslehi; Xavier Waintraub; Estelle Gandjbakhch; Anne Bachelot; Francoise Hidden-Lucet; Jean-Sebastien Hulot; Bjorn C Knollmann; Benedicte Lebrun-Vignes; Christian Funck-Brentano; Andrew M Glazer; Dan M Roden
Journal:  Circulation       Date:  2019-08-05       Impact factor: 29.690

Review 3.  Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.

Authors:  Peggy M Kostakou; Nikos T Kouris; Vassilios S Kostopoulos; Dimitrios S Damaskos; Christoforos D Olympios
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 4.  Cardio-toxicity of checkpoint inhibitors.

Authors:  Oliver J Müller; Martina E Spehlmann; Norbert Frey
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 5.  Cardiovascular adverse events in multiple myeloma patients.

Authors:  Markus B Heckmann; Shirin Doroudgar; Hugo A Katus; Lorenz H Lehmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 6.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Cardio-toxicity in childhood cancer survivors "Cure is not enough".

Authors:  Ulrich Neudorf; Anne Schönecker; Dirk Reinhardt
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 8.  Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Authors:  Lars Michel; Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 9.  Heart failure in cancer: role of checkpoint inhibitors.

Authors:  Murilo Delgobo; Stefan Frantz
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 10.  Modern concepts in cardio-oncology.

Authors:  Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.